- Program Access
- Overview & Objectives
- Program Materials
- Funding Support
| Duration: | 90 Minutes | |
|---|---|---|
| Details: | Dr. Narendra Singh: CHAMPION-AF: How does left atrial appendage occlusion compare to anticoagulation in AF? Dr. Milan Gupta: SCOUT-HCM: Extending the benefits of mavacamten to adolescents with obstructive hypertrophic cardiomyopathy. - Dr. Narendra Singh: CORALreef Add-On: How does an oral PCSK9 inhibitor compare to ezetimibe, bempedoic acid, or their combination? - Dr. Narendra Singh: Ez-PAVE: Is achieving a target LDL-C of <1.4 superior to <1.8 in patients with ASCVD? Dr. Milan Gupta: VESALIUS: Does evolocumab reduce events in patients with diabetes but without known atherosclerosis? Navigate using individual content links in the video |
|
Click Here To Watch 
|
||